Results 21 to 30 of about 132,795 (279)
Siriraj Medical Journal, 2018 Objective: To develop ultra-performance liquid chromatography-photodiode array detection (UPLC-PDA) method that is fully validated for measuring 11 antiretroviral drugs concentrations in human plasma.
Rasda Boonprasert, M.Sc. +4 more
doaj +3 more sources
Brazilian Journal of Infectious Diseases, 2015 Antiretroviral therapy has significantly evolved in the last decade, with an increasing number of new drugs and classes. Currently, even heavily experienced patients can be successfully treated with new regimens.
Carlos Brites +2 more
doaj +1 more source
Drug–drug interaction analysis: Antituberculosis drugs versus antiretroviral drugs
Biomedical and Biotechnology Research Journal, 2019 Background: Human immunodeficiency virus (HIV) infection is an important public health globally. An important concomitant medical disorder among HIV-infected patients is tuberculosis. The management of concurrent infection between HIV and tuberculosis is
Won Sriwijitalai, Viroj Wiwanitkit
doaj +1 more source
ANALISIS ADVERSE DRUG REACTIONS OBAT ANTI RETROVIRAL PADA PENGOBATAN PASIEN HIV/AIDS DI RSUD GUNUNG JATI CIREBON TAHUN 2013 [PDF]
Pharmaciana, 2016 Acquired Immunodeficiency Syndrome (AIDS) is a disease caused by infection with Human Immunodeficiency Virus (HIV). The pharmacology treatment for the infection was antiretroviral therapy.
Nur Rahmi Hidayati +2 more
doaj +1 more source
Siriraj Medical Journal, 2022 Objective: The present study aimed to describe the characteristics of occupational exposure to bloodborne pathogens and occupational post-exposure prophylaxis (oPEP) in Siriraj Hospital.
Narasak Changraksa +5 more
doaj +1 more source
Anti-retroviral drugs: current state and development in the next decade
Acta Pharmaceutica Sinica B, 2018 The pace of discovery of new antiretroviral (ARV) drugs has slowed, although the efficacy and safety of once-daily fixed dose combinations have been extensively investigated. Several traditional ARV drugs remain in phase III clinical trials.
Xingquan Zhang
doaj +1 more source
Focus on chirality of HIV-1 non-nucleoside reverse transcriptase inhibitors [PDF]
, 2016 Chiral HIV-1 non-nucleoside reverse transcriptase inhibitors (NNRTIs) are of great interest since one enantiomer is often more potent than the corresponding counterpart against the HIV-1 wild type (WT) and the HIV-1 drug resistant mutant strains.
Famiglini, Valeria, Silvestri, Romano
core +2 more sources
Current Perspectives on HIV-1 Antiretroviral Drug Resistance
Viruses, 2014 Current advancements in antiretroviral therapy (ART) have turned HIV-1 infection into a chronic and manageable disease. However, treatment is only effective until HIV-1 develops resistance against the administered drugs.
Pinar Iyidogan, Karen S. Anderson
doaj +1 more source
Журнал инфектологии, 2020 The purpose of this paper is to evaluate the spreading of HIV-1 resistant to antiretroviral drugs among Tomsk Oblast population with newly diagnosed HIV-infection.Materials and methods.
D. P. Zyryanova +7 more
doaj +1 more source
HIV-1 Integrase Strand Transfer Inhibitors and Neurodevelopment
Pharmaceuticals, 2022 Children born to mothers, with or at risk, of human immunodeficiency virus type-1 (HIV-1) infection are on the rise due to affordable access of antiretroviral therapy (ART) to pregnant women or those of childbearing age.
Emma G. Foster +2 more
doaj +1 more source